Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

372 trials

NCT07818668
Recruiting
tACS for Self-Other Boundary in Schizophrenia
Not applicable · China · 1 site
Registry update: 17 Sept 2026
NCT07467993
Recruiting
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Phase 2 · Bulgaria, United States · 15 sites
Registry update: 29 Jul 2026
NCT07290738
Recruiting
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
Not applicable · United States · 1 site
Registry update: 24 Mar 2026
NCT07615426
Recruiting
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Phase 1 · United States · 8 sites
Registry update: 3 Nov 2026
NCT07455929
Recruiting
Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders
Not applicable · Germany · 1 site
Registry update: 11 Mar 2026
NCT07379827
Recruiting
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Not applicable · United States · 68 sites
Registry update: 2 Nov 2026
NCT07252206
Recruiting
A Case Series of Culturally-adapted CBTp for Black People in the UK
Not applicable · United Kingdom · 1 site
Registry update: 10 Jul 2026
NCT07288333
Recruiting
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
Phase 2 · Bulgaria, United Kingdom, Croatia, Poland, Romania · 15 sites
Registry update: 22 Jul 2026
NCT07509125
Recruiting
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
Not applicable · Belgium · 1 site
Registry update: 3 Apr 2026
NCT07410507
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
Phase 2 · Argentina, Brazil, China, India, Japan, Taiwan, United States · 101 sites
Registry update: 7 Oct 2026
NCT07196423
Recruiting
Early Psychosis: Investigating Cognition
Not applicable · United Kingdom · 1 site
Registry update: 4 May 2026
NCT06774417
Recruiting
Digital Strategies to Advance Help-Seeking - Aim 3
Not applicable · United States · 1 site
Registry update: 18 Jun 2026
NCT06155682
Recruiting
TMS for Inhibition Enhancement in Schizophrenia
Not applicable · United States · 1 site
Registry update: 13 Feb 2026
NCT07469384
Recruiting
Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways
Not applicable · United States · 1 site
Registry update: 13 Mar 2026
NCT07428460
Recruiting
Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
Not applicable · Canada · 3 sites
Registry update: 20 Aug 2026
NCT06758414
Recruiting
CBT-CP for Veterans With SMI
Not applicable · United States · 1 site
Registry update: 9 Feb 2026
NCT07395206
Recruiting
Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
Not applicable · Germany · 1 site
Registry update: 3 Mar 2026
NCT07288567
Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Colombia, Japan, Romania, United States · 36 sites
Registry update: 6 Oct 2026
NCT07397975
Recruiting
Speech-based Assessment of Relapse Risk in People With Psychosis
Not applicable · Switzerland, Czechia, Ireland, Netherlands, Norway · 7 sites
Registry update: 9 Feb 2026
NCT07184619
Recruiting
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia
Phase 3 · Argentina, India, Malaysia, United States · 19 sites
Registry update: 10 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.